美国急性脑室引流市场规模、份额、趋势分析报告（按应用、患者类型、细分市场预测），2025-2030 年

市场规模与趋势：

预计 2024 年美国急性脑室引流市场规模将达到 8,650 万美元，2025 年至 2030 年的复合年增长率为 7.9%。

预计这一增长将受到非创伤性水脑症患病率上升、对微创或非侵入性神经外科手术的需求增加以及技术改进设备的采用率上升的推动。由于事故、运动伤害和中风发生率的增加，对外部脑室引流（EVD）手术的需求正在稳步增长。

随着老龄化社会的扩大，中风和动脉瘤等疾病的发病率不断上升，进一步增加了对脑血管疾病 (EVD) 手术的需求。例如，根据世界银行集团的数据，2018 年美国65 岁及以上人口总数为 4,998 万，预计到 2023 年将成长至 5,838 万。医疗基础设施的进步以及配备处理急性神经系统疾病的急诊和创伤中心的增加也促进了市场的成长。

EVD 系统的技术创新，例如改进的导管设计、抗菌涂层和整合监测功能，改善了患者的治疗效果并降低了感染风险，使这些设备对医疗保健提供者更具吸引力。越来越多的医院和诊所采用这些先进的 EVD 系统，以提高治疗效率并最大限度地减少併发症。此外，人们对微创神经外科的日益重视也推动了 EVD 的需求，因为 EVD 可以以比传统手术方法创伤更小的方式处理脑脊髓液排放。

推动市场扩张的另一个因素是美国医疗支出的不断增长以及神经外科手术的优惠报销政策。根据美国医疗保险和医疗补助服务中心的数据，预计到2023年，美国的医疗支出将增加7.5%，达到4.9兆美元，相当于每人14,570美元。脑血管病变（EVD）植入及相关治疗的保险覆盖范围将扩大患者的可及性，并鼓励医院投资这些设备。此外，医生越来越意识到在重症加护环境中早期有效脑脊髓液管理的益处，这也推动了脑脊髓液的采用率。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国急性脑室引流市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 分析美国急性脑室引流市场的工具
  • 产业分析-波特五力分析
  • PESTEL分析
• 美国急性脑室引流市场：管道分析

第四章。美国急性脑室引流市场：应用估计与趋势分析

• 按用途细分仪表板
• 美国急性脑室引流市场：应用趋势分析
• 美国急性脑室引流市场规模及应用趋势分析（2018-2030）
• 创伤性脑损伤
• 蜘蛛网膜下腔出血
• 脑出血
• 其他非创伤性水脑症

第五章美国急性脑室引流市场：依病患类型估计与趋势分析

• 按患者类型细分仪表板
• 美国急性脑室引流市场：依病患类型进行的变化分析
• 2018-2030年美国急性脑室引流市场规模及趋势分析（依病患类型）
• 孩子们
• 成人

第六章 竞争态势

• 主要市场参与企业的近期趋势和影响分析
• 公司/竞争对手分类
• 供应商格局
  • Key company heat map analysis, 2024
• 公司简介
  • Medtronic
  • Integra LifeSciences Corporation
  • Anuncia Medical, Inc.
  • Natus
  • Fuji Systems
  • B Braun/Aesculap
  • Boston Scientific
  • Abbott

Market Size & Trends:

The U.S. acute external ventricular drain market size was valued at USD 86.5 million in 2024 and is projected to grow at a CAGR of 7.9% from 2025 to 2030. The growth is expected to be driven by the rising prevalence of non-traumatic hydrocephalus, increased demand for minimal or noninvasive neurosurgeries, and the rising adoption of technologically improved devices. With the growing incidence of accidents, sports injuries, and strokes, the demand for external ventricular drain (EVD) procedures is rising steadily.

As the aging population expands, the prevalence of conditions like strokes and aneurysms rises, further boosting the need for EVD procedures. For instance, according to the World Bank Group, the total population aged 65 and above in the U.S. was 49.98 million in 2018, increasing to 58.38 million in 2023. In addition, advancements in healthcare infrastructure and the rising number of emergency and trauma centers equipped to handle acute neurological cases contribute to market growth.

Technological innovations in EVD systems, such as improved catheter designs, antimicrobial coatings, and integrated monitoring capabilities, enhance patient outcomes and reduce infection risks, making these devices more appealing to healthcare providers. Hospitals and clinics increasingly adopt these advanced EVD systems to improve treatment efficiency and minimize complications. Moreover, the growing emphasis on minimally invasive neurosurgical techniques supports the demand for EVDs, as they offer a less invasive solution for managing CSF drainage than traditional surgical methods.

Another factor fueling market expansion is the rising healthcare expenditure in the U.S., coupled with favorable reimbursement policies for neurological procedures. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased by 7.5% in 2023, reaching USD 4.9 trillion, which amounts to USD 14,570 per person. Insurance coverage for EVD placements and related treatments ensures broader patient access, encouraging hospitals to invest in these devices. Furthermore, increased physician awareness about the benefits of early and effective CSF management in critical care settings drives higher adoption rates.

U.S. Acute External Ventricular Drain Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. acute external ventricular drain market report based on application, and patient type.

• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Traumatic Brain Injury
• Subarachnoid hemorrhage
• Intracerebral hemorrhage
• Other Non-Traumatic Hydrocephalus conditions
• Patient Type Outlook (Revenue, USD Million, 2018 - 2030)
• Pediatric
• Adult

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Patient Type
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Patient type outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Acute External Ventricular Drain Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Acute External Ventricular Drain Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. U.S. Acute External Ventricular Drain Market: Pipeline Analysis

Chapter 4. U.S. Acute External Ventricular Drain Market: Application Estimates & Trend Analysis

• 4.1. Application Segment Dashboard
• 4.2. U.S. Acute External Ventricular Drain Market: Application Movement Analysis
• 4.3. U.S. Acute External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Traumatic Brain Injury
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD million)
• 4.5. Subarachnoid Hemorrhage
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Intracerebral Hemorrhage
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Other Non-Traumatic Hydrocephalus Conditions
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Acute External Ventricular Drain Market: Patient Type Estimates & Trend Analysis

• 5.1. Patient Type Segment Dashboard
• 5.2. U.S. Acute External Ventricular Drain Market: Patient Type Movement Analysis
• 5.3. U.S. Acute External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
• 5.4. Pediatric
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Adult
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. Key company heat map analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Medtronic
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Integra LifeSciences Corporation
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Anuncia Medical, Inc.
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Natus
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Fuji Systems
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. B Braun/Aesculap
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. Boston Scientific
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Abbott
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. acute external ventricular drain market, by application, 2018-2030 (USD Million)
• Table 3 U.S. acute external ventricular drain market, by patient type, 2018-2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. acute external ventricular drain market: market outlook
• Fig. 10 U.S. acute external ventricular drain competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. acute external ventricular drain market driver impact
• Fig. 16 U.S. acute external ventricular drain market restraint impact
• Fig. 17 U.S. acute external ventricular drain market strategic initiatives analysis
• Fig. 18 U.S. acute external ventricular drain market: Application movement analysis
• Fig. 19 U.S. acute external ventricular drain market: Application outlook and key takeaways
• Fig. 20 Traumatic brain injury market estimates and forecasts, 2018 - 2030
• Fig. 21 Subarachnoid hemorrhage market estimates and forecasts, 2018 - 2030
• Fig. 22 Intracerebral hemorrhage market estimates and forecasts, 2018 - 2030
• Fig. 23 Other non-traumatic hydrocephalus conditions market estimates and forecasts, 2018 - 2030
• Fig. 24 U.S. acute external ventricular drain market: Patient Type movement analysis
• Fig. 25 U.S. acute external ventricular drain market: Patient Type outlook and key takeaways
• Fig. 26 Pediatric market estimates and forecasts, 2018 - 2030
• Fig. 27 Adult market estimates and forecasts, 2018 - 2030